arrow
返回
C

Carol A. Lange

university of minnesota

59H指数
315论文数
1.3W被引数
收录论文 97
发表时间
err分享
err收藏
Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation孕酮受体在ESR1突变背景下驱动晚期乳腺癌表型,包括循环肿瘤细胞和类干细胞的增殖。
err2026-04-07
err0
errOAAI
errThu H. Truong; Noelle E. Gillis; Amy R. Dwyer; Rosemary J. Huggins; Kyla M. Hagen; Sai Harshita Posani; Nuri A. Temiz; Carlos Perez Kerkvliet; Ellie M. Piepgras; Julie H. Ostrander; Geoffrey L. Greene; Carol A. Lange
err分享
err收藏
In memoriam: Brian J. Harvey纪念:Brian J. Harvey
err2025-11-01
err0
PREAI
errBarton, Matthias; Lange, Carol A.; Levin, Ellis R.; Prossnitz, Eric R.; Rossi, Gian Paolo; Rapetti-mauss, Raphael
err分享
err收藏
Stemness-targeted therapies to inhibit cancer cell plasticity in triple negative breast cancer靶向干细胞特性的疗法以抑制三阴性乳腺癌的癌细胞可塑性
err2024-09-01
err0
PREAI
errTakchi, A.; Haddad, T.; Zhang, M.; Jalalirad, M.; Suman, V.; Wang, L.; Lange, C.; Ingle, J.; Goetz, M. P.; DAssoro, A. B.
err分享
err收藏
Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER plus Breast Cancer
err2024-07-23
err3
PREAI
errDiep, Caroline H.; Spartz, Angela; Truong, Thu H.; Dwyer, Amy R.; El-Ashry, Dorraya; Lange, Carol A.
err分享
err收藏
Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer阻断肿瘤细胞内在PD-L1信号增强三阴性乳腺癌的AURKA靶向治疗
err2024-05-30
err1
errOAAI
errTakchi, Andrew; Zhang, Minzhi; Jalalirad, Mohammad; Ferre, Roberto Leon; Shrestha, Royal; Haddad, Tufia; Sarkaria, Jann; Tuma, Ann; Carter, Jodi; David, Hillman; Giridhar, Karthik; Wang, Liewei; Lange, Carol; Lendahl, Urban; Ingle, James; Goetz, Matthew; D'Assoro, Antonino Bonaventura
err分享
err收藏
Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis
err2024-04-05
err0
PREAI
errGuo, Zhijun; Lei, Jianxun; Makovec, Allison; Jayaraman, Swaathi; Hawse, John R.; Lange, Carol; Ambrose, Elizabeth; Georg, Gunda I.; D'Assoro, Tony; Matthew, Goetz P.; Potter, David A.
err分享
err收藏
Context matters: Genomic profiling of PR isoform-specific actions in breast cancer stem cells reveals novel therapeutic insights for ER plus breast cancer
err2024-03-22
err0
PREAI
errGillis, Noelle E.; Truong, Thu H.; Finlay-Schultz, Jessica; Sartorius, Carol A.; Lange, Carol A.
err分享
err收藏
Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4
err2023-05-24
err13
PREAI
errDwyer, Amy R.; Kerkvliet, Carlos Perez; Truong, Thu H.; Hagen, Kyla M.; Krutilina, Raisa, I; Parke, Deanna N.; Oakley, Robert H.; Liddle, Christopher; Cidlowski, John A.; Seagroves, Tiffany N.; Lange, Carol A.
err分享
err收藏
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients透明质酸介导的运动受体 (RHAMM) 定义了与肿瘤进展相关的侵袭性生态位,并预测乳腺癌患者的不良预后
err2023-04-26
err7
errOAAI
errTarullo, Sarah E.; He, Yuyu; Daughters, Claire; Knutson, Todd P.; Henzler, Christine M.; Price, Matthew A.; Shanley, Ryan; Witschen, Patrice; Tolg, Cornelia; Kaspar, Rachael E.; Hallstrom, Caroline; Gittsovich, Lyubov; Sulciner, Megan L.; Zhang, Xihong; Forster, Colleen L.; Lange, Carol A.; Shats, Oleg; Desler, Michelle; Cowan, Kenneth H.; Yee, Douglas; Schwertfeger, Kathryn L.; Turley, Eva A.; McCarthy, James B.; Nelson, Andrew C.
err分享
err收藏
The SMILE Study: A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors
err2023-03-01
err0
PREAI
errKamaraju, Sailaja; Fowler, Amy; Chaudhary, Lubna N.; Burkard, Mark; Giever, Thomas; Hegeman, Robert N.; Pipp-Dahm, Michele; Cheng, Yee Chung; Lange, Carol; Jorns, Julie M.; Stella, Amy; Siddiqui, Nauman; Zurbriggen, Luke; Rajguru, Saurabh; Tarima, Sergey; Sriram, Deepika; Retseck, Janet; Rui, Hallgeir; Sahmoud, Tarek; Wisinski, Kari B.
err分享
err收藏
Primary results of ONAWA (SOLTI-1802) trial: A window of opportunity trial of onapristone in postmenopausal women with progesterone receptor-positive/HER2-negative early breast cancer (EBC)
err2022-02-15
err1
PREAI
errBellet, Meritxell; Morales, Serafin; Gasol, Ariadna; Amillano, Kepa; Chic, Nuria; Gonzalez-Farre, Xavier; Villagrasa, Patricia; Pare, Laia; Falato, Claudette; Nuciforo, Paolo; Martinez, Debora; Ferrero-Cafiero, Juan M.; Pascual, Tomas; Prat, Aleix; Lange, Carol; Saura, Cristina
err分享
err收藏
The SMILE study: A phase 2 trial of onapristone in combination with fulvestrant for patients with ER+ and HER2-metastatic breast cancer after progression on endocrine therapy and CDK4/6 inhibitors
err2022-02-15
err0
PREAI
errKamaraju, Sailaja; Fowler, Amy; Cheng, Chung Yee; Chaudhary, Lubna N.; Burfeind, John; Retseck, Janet; Tevaarwerk, Amye J.; Burkard, Mark; Paplomata, Elisavet; Parkes, Amanda M.; Jorns, Julie M.; Tarima, Sergey; Yee, Douglas; Rui, Hallgeir; Lange, Carol; Sahmoud, Tarek; Wisinski, Kari B.
err分享
err收藏